(Q38197927)

30 August 2017

1 reference

title

Epigenetics of multiple sclerosis: an updated review (English)

1 reference

30 August 2017

0 references

Cem İsmail Küçükali

1

1 reference

30 August 2017

Murat Kürtüncü

2

1 reference

30 August 2017

Arzu Çoban

3

1 reference

30 August 2017

Merve Çebi

4

1 reference

30 August 2017

Erdem Tüzün

5

1 reference

30 August 2017

publication date

21 March 2014

1 reference

30 August 2017

published in

NeuroMolecular Medicine

1 reference

30 August 2017

volume

17

1 reference

30 August 2017

issue

2

1 reference

30 August 2017

page(s)

83-96

1 reference

https://scigraph.springernature.com/pub.10.1007/s12017-014-8298-6

30 August 2017

exact match

0 references

cites work

MicroRNAs in Sjögren's syndrome as a prototypic autoimmune disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Environmental risk factors for multiple sclerosis. Part I: The role of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

DNA methylation and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Molecular mechanisms mediated by human endogenous retroviruses (HERVs) in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Epigenetics lessons from twins: prospects for autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Genetics of multiple sclerosis: swimming in an ocean of data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

The DNA methyltransferases of mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Inflammatory caspases are critical for enhanced cell death in the target tissue of Sjögren's syndrome before disease onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Methylation-dependent PAD2 upregulation in multiple sclerosis peripheral blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Contribution of myelin autoantigen citrullination to T cell autoaggression in the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

microRNAs in vertebrate physiology and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Effects of insulin and glucose on cellular metabolic fluxes in homocysteine transsulfuration, remethylation, S-adenosylmethionine synthesis, and global deoxyribonucleic acid methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Interferon-beta treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

The CD27 and CD70 costimulatory pathway inhibits effector function of T helper 17 cells and attenuates associated autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Autocatalytic cleavage of myelin basic protein: an alternative to molecular mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Epigenetics: definition, mechanisms and clinical perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Parent-of-origin effect in multiple sclerosis: observations in half-siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Epigenetics in human disease and prospects for epigenetic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

STAT3 activates miR-155 in Th17 cells and acts in concert to promote experimental autoimmune uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

The therapeutic potential of HDAC inhibitors in the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Footprinting of mammalian promoters: use of a CpG DNA methyltransferase revealing nucleosome positions at a single molecule level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Epigenetic differences arise during the lifetime of monozygotic twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Analysis of sirtuin 1 expression reveals a molecular explanation of IL-2-mediated reversal of T-cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Perspectives and future directions for epigenetics in hematology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

The genetics of multiple sclerosis: an up-to-date review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Targeting histone deacetylase activity in rheumatoid arthritis and asthma as prototypes of inflammatory disease: should we keep our HATs on?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Rationale for the use of histone deacetylase inhibitors as a dual therapeutic modality in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

CD44 Reciprocally regulates the differentiation of encephalitogenic Th1/Th17 and Th2/regulatory T cells through epigenetic modulation involving DNA methylation of cytokine gene promoters, thereby controlling the development of experimental autoimmun

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

MicroRNA expression changes during interferon-beta treatment in the peripheral blood of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Cigarette smoking and incidence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Histone deacetylase gene variants predict brain volume changes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

HDAC1 and HDAC2 control the transcriptional program of myelination and the survival of Schwann cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Prevalence of ZAP-70, LAT, SLP-76, and DNA methyltransferase 1 expression in CD4+ T cells of patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

DNA hypomethylation in rheumatoid arthritis synovial fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

The natural history of primary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Epigenetic changes in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Peripheral B cell abnormalities in patients with systemic lupus erythematosus in quiescent phase: decreased memory B cells and membrane CD19 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Chromatin modifications and their function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Environmental risk factors in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Procainamide is a specific inhibitor of DNA methyltransferase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Genetics meets epigenetics: HDACs and Wnt signaling in myelin development and regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Methylation patterns of cell-free plasma DNA in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Decreased DNA methyltransferase levels contribute to abnormal gene expression in "senescent" CD4(+)CD28(-) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

The ligase PIAS1 restricts natural regulatory T cell differentiation by epigenetic repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Demethylation of CD40LG on the inactive X in T cells from women with lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Critical role of TCF-1 in repression of the IL-17 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylated

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Subversion of B lymphocyte tolerance by hydralazine, a potential mechanism for drug-induced lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

The role of charge microheterogeneity of basic protein in the formation and maintenance of the multilayered structure of myelin: a possible role in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Myelin in multiple sclerosis is developmentally immature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Cell cycle controlling the silencing and functioning of mammalian activators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Deimination of membrane-bound myelin basic protein in multiple sclerosis exposes an immunodominant epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Impaired neurosteroid synthesis in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Multiple sclerosis genetics--is the glass half full, or half empty?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Differential micro RNA expression in PBMC from multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Identification of microRNA-221/222 and microRNA-323-3p association with rheumatoid arthritis via predictions using the human tumour necrosis factor transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Changed histone acetylation patterns in normal-appearing white matter and early multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Multiple sclerosis: risk factors, prodromes, and potential causal pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

CpG methylation, chromatin structure and gene silencing-a three-way connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Epigenetic reprogramming in mammalian development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

LINE-1 hypomethylation in noncancerous esophageal mucosae is associated with smoking history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Towards a complete resolution of the genetic architecture of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Effect of low saturated fat diet in early and late cases of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Risk alleles for multiple sclerosis identified by a genomewide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

DNA methylation and the expanding epigenetics of T cell lineage commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

DNA methylation in T cells from idiopathic lupus and drug-induced lupus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Parental transmission of HLA-DRB1*15 in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-014-8298-6

Abnormal histone modification patterns in lupus CD4+ T cells

21 January 2018

1 reference

12 December 2020

Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis

1 reference

12 December 2020

The genetics of multiple sclerosis: review of current and emerging candidates

1 reference

12 December 2020

Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production

1 reference

12 December 2020

Hypomethylation of IL10 and IL13 promoters in CD4+ T cells of patients with systemic lupus erythematosus

1 reference

12 December 2020

Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A

1 reference

12 December 2020

Methylation differences at the HLA-DRB1 locus in CD4+ T-Cells are associated with multiple sclerosis.

1 reference

12 December 2020

Histone deacetylase activity is necessary for oligodendrocyte lineage progression.

1 reference

12 December 2020

DNA methylation is a nonredundant repressor of the Th2 effector program

1 reference

12 December 2020

Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation

1 reference

12 December 2020

Genetic and epigenetic influence on EAE phenotypes induced with different encephalitogenic peptides

1 reference

12 December 2020

High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis

1 reference

12 December 2020

Histone deacetylase sirtuin 1 deacetylates IRF1 protein and programs dendritic cells to control Th17 protein differentiation during autoimmune inflammation

1 reference

12 December 2020

Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation

1 reference

12 December 2020

Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo

1 reference

12 December 2020

1 reference

12 December 2020

Expression of transfected human interferon-gamma DNA: evidence for cell-specific regulation.

1 reference

12 December 2020

Enhanced T cell responsiveness to citrulline-containing myelin basic protein in multiple sclerosis patients

1 reference

12 December 2020

Differentiation of the T helper phenotypes by analysis of the methylation state of the IFN-gamma gene

1 reference

12 December 2020

DNA methylation modulates HRES1/p28 expression in B cells from patients with Lupus

1 reference

12 December 2020

Role of the CD6 glycoprotein in antigen-specific and autoreactive responses of cloned human T lymphocytes.

1 reference

12 December 2020

Effect of an inhibitor of DNA methylation on T cells. II. 5-Azacytidine induces self-reactivity in antigen-specific T4+ cells

1 reference

12 December 2020

Mechanisms of drug-induced lupus. IV. Comparison of procainamide and hydralazine with analogs in vitro and in vivo

1 reference

12 December 2020

Hypomethylation of LINE-1 but not Alu in lymphocyte subsets of systemic lupus erythematosus patients

1 reference

12 December 2020

10.1007/S12017-014-8298-6

Identifiers

DOI

1 reference

Dimensions Publication ID

30 August 2017

1052820736

0 references

1 reference